ATAN, A. 2019. Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.10 , 1781-1782.

ATAN, A., (2019). Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.10, 1781-1782.

ATAN, ALİ. "Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.10, 1781-1782, 2019

ATAN, ALİ. "Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.10, pp.1781-1782, 2019

ATAN, A. (2019) . "Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.10, pp.1781-1782.

@article{article, author={ALİ ATAN}, title={Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2019, pages={1781-1782} }